• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Saudi Arabia’s Four-Year High in US Treasury Bonds

user avatar

by Giorgi Kostiuk

a year ago


Saudi Arabia's investments in US Treasury bonds have reached their highest level since 2020, despite a decline in total reserves.

Rise of Saudi Investments in US Bonds

Saudi Central Bank (SAMA) reports that investments in US Treasury bonds have hit $144 billion, making up 35% of the kingdom's total foreign assets. This is the largest share since February 2020, coinciding with the onset of the COVID-19 pandemic. However, Saudi Arabia's total foreign reserves have dropped to $411 billion, marking a low since February 2020.

Strategic Reallocation of Reserves

The decline in reserves reflects a mix of economic strategy and fiscal necessity, following a sharp drop after a $40 billion transfer to the Public Investment Fund (PIF) during global market turmoil. This was an opportune moment to acquire discounted assets. The potential return of Donald Trump to the White House could strengthen Saudi Arabia’s political and economic ties with the US.

Rising Bond Yields and Market Expectations

Treasury yields increased as investors prepared for important labor and manufacturing data releases. The 10-year Treasury yield rose by 1 basis point to 4.207%, while the 2-year yield increased by 2 basis points to 4.192%. Investors are focused on upcoming data, including employment reports and unemployment rate updates, with an expected job increase for November.

Saudi Arabia's investments in US Treasury bonds reflect a strategic approach to managing financial reserves amidst a shifting political and economic landscape.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.